Cannim Group and Cannim Australia Enter Voluntary Administration Amid Cash Flow Strain

International medical cannabis producer Cannim Group and its Australian subsidiary Cannim Australia have entered voluntary administration, marking the latest setback for the nascent legal medical cannabis sector. Michael Billingsley, Neil Cussen and Rajiv Goyal of Olvera Advisors were appointed administrators on 27 October 2025, following months of liquidity pressure and unsuccessful efforts to stabilise cash flow.

Founded in 2017, Cannim cultivates and distributes pharmaceutical-grade cannabis products into legal medical cannabis markets including Australia, the UK, and the US. The group gained global attention in 2021 after completing the first-ever legal export of Jamaican cannabis flower to Germany, positioning itself as an early mover in international medical cannabis supply chains. However, tightening capital markets, pricing pressures, and high compliance costs have weighed heavily on operations.

The administrators said they are assessing restructuring and sale options to preserve value across Cannim’s international network while maintaining continuity of supply to patients and customers. A first creditors’ meeting is scheduled for 6 November, where the administrators will outline the company’s financial position and next steps.